The epidemiology of biopsy-positive giant cell arteritis: Special reference to cyclic fluctuations

Rheumatology

Volumn 38, Issue 12, 1999, Pages 1208-1212

  Petursdottir, V ^a   Johansson, H ^a   Nordborg, E ^a   Nordborg, C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Giant cell arteritis; Incidence; Infections; Periodicity

Indexed keywords

ADULT; ARTICLE; BIOPSY; FEMALE; GIANT CELL ARTERITIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL VARIATION; STATISTICAL ANALYSIS; SWEDEN; TEMPORAL ARTERY; TIME; WINTER;

EID: 0032762675     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.12.1208     Document Type: Article

References (41)

1. Andersson R, Jonsson R, Tarkowski A, Bengtsson BA, Malmvall BE. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 1987;46:915-23.
2. Weyand CM, Schonberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994;179:951-60.
3. Nordborg E, Bengtsson BA, Nordborg C. Temporal artery morphology and morphometry in giant cell arteritis. APMIS 1991;99:1013-23.
4. Richardson JE, Gladman DD, Fam A, Keystone EC. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987;30:1293-7.
5. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
6. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-12.
7. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981;24:899-904.
8. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982 1985. Arthritis Rheum 1987;30:294-9.
9. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984 1988. J Rheumatol 1992;19:273-6.
10. Nordborg E, Bengtsson BA. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 1990; 227:233-6.
11. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
12. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
13. Gonzalez Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez Camblor B, Sanchez Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 1992;19:277-80.
14. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991;34:351-6.
15. Friedman G, Friedman B, Benbassat J. Epidemiology of temporal arteritis in Israel. Isr J Med Sci 1982;18:241-4.
16. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994;33:938-41.
17. Sanford RG, Berney SN. Polymyalgia rheumatica and temporal arteritis in blacks clinical features and HLA typing. J Rheumatol 1977;4:435-42.
18. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-9.
19. Chakravarty K, Merry P. Polymyalgia rheumatica - a delayed sequelae of Borrelia infection? [Letter] Br J Rheumatol 1992;31:647-8.
20. Cimmino MA, Grazi G, Balistreri M, Accardo S. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:309-13.
21. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-9.
22. Fest T, Mougin C, Dupond JL. Giant cell arteritis. [Letter] Ann Intern Med 1996;124:927-8.
23. Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M et al. Search for varicella zoster virus in giant cell arteritis. Ann Neurol 1998;44:413-4.
24. Pizzarello LD, MacDonald AB, Semlear R, DiLeo F, Berger B. Temporal arteritis associated with Borrelia infection. A case report. J Clin Neuroophthalmol 1989;9:3-6.
25. Russo MG, Waxman J, Abdoh AA, Serebro LH. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 1995;38:374-80.
26. Staud R, Corman LC. Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis 1996; 22:1123.
27. Vaith P, Rother E, Vogt A, Peter HH. Polymyalgia rheumatica nach Borrelieninfektion. Immun Infekt 1988;16:71-3.
28. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
29. Lie JT. When is arteritis of the temporal arteries not temporal arteritis? J Rheumatol 1994;21:186-9.
30. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand (A) 1973;237:1-59.
31. Statistical Year Book of Göteborg (Statistisk Årsbok Göteborg). Göteborg: Göteborg Municipal Office (Göteborgs Stadskansli), 1977-1996.
32. Breslow NE, Day NE. Statistical methods in cancer research. Lyon: IARC Scientific Publications No. 32, 1987:131-5.
33. Maxwell AE. Analyzing qualitative data. London: Methuen, 1961:63-72.
34. Gonzalez Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez Camblor B, Sanchez Andrade A. Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. [Letter] Arthritis Rheum 1992;35:1249-50.
35. Kinmont PDC, McCallum DI. The etiology and course of giant cell arteritis. The possible role of light sensitivity. Br J Dermatol 1965;77:193-202.
36. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 1979;24:111-7.
37. Duhaut P, Pinède L, Demolombe-Ragué S, Dumontet C, Ninet J, Seydoux D et al. Giant cell arteritis, polymyalgia rheumatica, and viral hypothesis: a multicenter, prospective case-control study. Groupe de Recherche sur l'Arterite a Cellules Geantes. J Rheumatol 1999;26:361-9.
38. Bacon PA, Doherty SM, Zuckerman AJ. Hepatitis-B antibody in polymyalgia rheumatica. Lancet 1975;2:476-8.
39. Elling H, Skinhoj P, Elling P. Hepatitis B virus and polymyalgia rheumatica: a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb. Ann Rheum Dis 1980; 39:511-3.
40. Liang M, Greenberg H, Pincus T, Robinson WS. Hepatitis-B antibody in polymyalgia rheumatica. [Letter] Lancet 1976;1:43.
41. Permin H, Aldershvile J, Nielsen JO. Hepatitis B virus infection in patients with rheumatic diseases. Ann Rheum Dis 1982;41:479-82.